If you're feeling unwell, get tested for COVID-19 and stay home until you’ve received a negative result. View our latest COVID-19 updates.
Located on the 'Parkville strip', we’re ranked #2 in the world in Pharmacy and Pharmacology. We’re determined to deliver life-changing results. Find out more.
Turn curiosity into a cure with an undergrad, postgrad or research degree in pharmacy and pharmaceutical sciences. Study in our high-tech $75 million Parkville campus.
Join Australia’s leading pharmaceutical researchers, world famous for fighting flu, malaria, cancer and more. Find out about our new enhanced doctoral program.
Every day, our researchers dedicate their time to designing better medicines and improving healthcare. Discover our global impact.
The Faculty offers a wide selection of ways to engage with our students. As leaders in the industry, you have the opportunity to help shape the leaders of the next generation, assist in skill development and have the chance to talent spot.
Explore our innovative learning initiatives for students and staff like our virtual-practice environments and PharmAcademy.
You never really leave Monash, and it never really leaves you. Stay connected here.
Student support, course information, dates, policies, and everything else to help you succeed.
You are here:
Browse: ▾
Professor Jonathan Baell from the Medicinal Chemistry theme of the Monash Institute of Pharmaceutical Sciences (MIPS) has been awarded a Project Grant from MS Research Australia to develop a new test to monitor multiple sclerosis (MS) disease
The Commonwealth Government’s Medical Research Future Fund (MRFF) has invested just over $1.5 million to begin the Phase 1 clinical trial of two Melbourne-based COVID-19 vaccine candidates.
Lund, December 22, 2020. Iconovo AB (publ) today announced that the company has signed a development agreement with Monash University for the development of inhaled oxytocin
Researchers from Monash University and the Florey Institute have made a potential breakthrough in the ability to treat alcohol addiction with a simple drug.
Two scientists from the Monash Institute of Pharmaceutical Sciences (MIPS) have been awarded 2020 National Health and Medical Research Council (NHMRC) Ideas Grants, worth more than $2 million combined.
Digestion specialist, Dr Andrew Clulow, from the Monash Institute of Pharmaceutical Sciences (MIPS) is continuing to break ground in the world of milk and infant nutrition discoveries with a new study that has shown that mixing cow milk fat with
A long running collaboration between scientists at the Monash Institute of Pharmaceutical Sciences (MIPS) and Melbourne-based biotechnology company Starpharma has been awarded $433,000 through the ARC linkage scheme.
A new nationwide study led by Monash University has found that the rate of supply for hormonal long-acting reversible contraception (LARC) in Australia began to plateau from 2015.
Monash University’s Medicines Manufacturing Innovation Centre (MMIC) has been recognised as a leading light in Australia's COVID-19 response and scientific collaboration with a
